Kollmannsberger, C. et al. 2025. Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategies. Canadian Urological Association Journal. 19, 8 (Apr. 2025), 282–8. DOI:https://doi.org/10.5489/cuaj.9100.